FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

765663002: Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3674142015 Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet en Synonym Active Case insensitive SNOMED CT core
3674143013 Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Bumetanide and potassium chloride only product in oral dose form true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Plays role Loop diuretic therapeutic role true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has BoSS Bumetanide true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Bumetanide true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has BoSS Potassium chloride true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit mcg true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Potassium chloride true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has manufactured dose form Extended-release oral tablet true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Bumetanide-containing product in oral dose form false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has unit of presentation Tablet true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Potassium chloride-containing product in oral dose form false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Potassium chloride false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator value 500 false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit mcg false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has BoSS Bumetanide false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has precise active ingredient Bumetanide false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has BoSS Potassium chloride false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator value 573 false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Count of base of active ingredient 2 false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Unit of use quantity reference set

Description inactivation indicator reference set

Back to Start